Bezlotoxumab during the first episode of Clostridioides difficile infection in patients at high risk of recurrence. Escudero-Sanchez R, Ramos-Martinez A, Caballero-Bermejo AF, Diaz-Pollan B, et al. Eur J Clin Microbiol Infect Dis 2024;43:533-540.

Read + Share

Amedeo Smart

Independent Medical Education

Escudero-Sanchez R, Ramos-Martinez A, Caballero-Bermejo AF, Diaz-Pollan B, et al. Bezlotoxumab during the first episode of Clostridioides difficile infection in patients at high risk of recurrence. Eur J Clin Microbiol Infect Dis 2024;43:533-540.
PMID: 38236366